Stocks and Investing
Stocks and Investing
Tue, May 23, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Hartaj Singh Reiterated (SPRB) at Buy and Held Target at $8 on, May 23rd, 2023
Hartaj Singh of Oppenheimer, Reiterated "Spruce Biosciences, Inc." (SPRB) at Buy and Held Target at $8 on, May 23rd, 2023.
Hartaj has made no other calls on SPRB in the last 4 months.
There are 4 other peers that have a rating on SPRB. Out of the 4 peers that are also analyzing SPRB, 0 agree with Hartaj's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Hartaj
- Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $8 on, Tuesday, May 16th, 2023
- Jonathan Wolleben of "JMP Securities" Reiterated at Buy and Held Target at $7 on, Tuesday, May 16th, 2023
- Tiago Fauth of "Credit Suisse" Reiterated at Buy and Held Target at $4 on, Tuesday, May 16th, 2023
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $10 on, Thursday, March 23rd, 2023
Contributing Sources